<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>H4C Net &#187; Prescription Drugs</title>
	<atom:link href="http://www.h4c.net/category/personal-health/prescription-drugs/feed" rel="self" type="application/rss+xml" />
	<link>http://www.h4c.net</link>
	<description>Health 4 Care Resources</description>
	<lastBuildDate>Wed, 05 May 2010 03:23:29 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.5</generator>
		<item>
		<title>Drug Labeling Puts People With Vision Loss At Medical Risk</title>
		<link>http://www.h4c.net/personal-health/prescription-drugs/drug-labeling-puts-people-with-vision-loss-at-medical-risk.html</link>
		<comments>http://www.h4c.net/personal-health/prescription-drugs/drug-labeling-puts-people-with-vision-loss-at-medical-risk.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:04:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prescription Drugs]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Medicine]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14492</guid>
		<description><![CDATA[Would you feel safe taking a dose of medication if you were not fully confident you were taking the correct amount? What would you do if you couldn&#8217;t read important drug information on prescription bottles or package inserts? For the more than 20 million people living with vision loss, not being able to read drug [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/personal-health/prescription-drugs/drug-labeling-puts-people-with-vision-loss-at-medical-risk.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Improves Safety Of Drugs, Active Drug Ingredients</title>
		<link>http://www.h4c.net/personal-health/prescription-drugs/fda-improves-safety-of-drugs-active-drug-ingredients.html</link>
		<comments>http://www.h4c.net/personal-health/prescription-drugs/fda-improves-safety-of-drugs-active-drug-ingredients.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:04:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prescription Drugs]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14475</guid>
		<description><![CDATA[The U.S. Food and Drug Administration today announced the launch of a voluntary pilot program that would help promote the safety of drugs and active drug ingredients produced outside the United States. The FDA plans to select 100 applicants to participate in the Secure Supply Chain pilot program. To qualify, applicants will need to meet [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/personal-health/prescription-drugs/fda-improves-safety-of-drugs-active-drug-ingredients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel Vaccines Improve Potential For European Vaccines Manufacturers</title>
		<link>http://www.h4c.net/personal-health/prescription-drugs/novel-vaccines-improve-potential-for-european-vaccines-manufacturers.html</link>
		<comments>http://www.h4c.net/personal-health/prescription-drugs/novel-vaccines-improve-potential-for-european-vaccines-manufacturers.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:03:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prescription Drugs]]></category>
		<category><![CDATA[Health]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14449</guid>
		<description><![CDATA[The vaccines market, which was earlier associated with low profit margins and slow growth rates, has gained momentum in recent years through innovation. The introduction of novel vaccines for diseases with high burden and continuous investments aimed at boosting production capacity is driving the growth of this previously unattractive market. New analysis from Frost %26amp; [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/personal-health/prescription-drugs/novel-vaccines-improve-potential-for-european-vaccines-manufacturers.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tramadol Added To Kentucky Prescription Drug Monitoring System</title>
		<link>http://www.h4c.net/personal-health/prescription-drugs/tramadol-added-to-kentucky-prescription-drug-monitoring-system.html</link>
		<comments>http://www.h4c.net/personal-health/prescription-drugs/tramadol-added-to-kentucky-prescription-drug-monitoring-system.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:02:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prescription Drugs]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14444</guid>
		<description><![CDATA[The Cabinet for Health and Family Services Office of Inspector General (OIG) is increasing efforts to monitor the types and amounts of potentially addictive prescription drugs dispensed to Kentuckians, recently becoming only the second state to add the drug Tramadol to its list of controlled substances. Tramadol, which is intended to alleviate pain, has been [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/personal-health/prescription-drugs/tramadol-added-to-kentucky-prescription-drug-monitoring-system.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Savella For Fibromyalgia Management</title>
		<link>http://www.h4c.net/personal-health/prescription-drugs/fda-approves-savella-for-fibromyalgia-management.html</link>
		<comments>http://www.h4c.net/personal-health/prescription-drugs/fda-approves-savella-for-fibromyalgia-management.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:01:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prescription Drugs]]></category>
		<category><![CDATA[Medicine]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14420</guid>
		<description><![CDATA[Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function, afflicting as [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/personal-health/prescription-drugs/fda-approves-savella-for-fibromyalgia-management.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

